Robert A. Preti PhD

Dr. Robert A. Preti is Progenitor Cell Therapy, LLC’s (PCT) co-founder, president, and chief scientific officer. Through his administrative duties, Dr. Preti has overseen the growth of PCT from its inception to its position as a world-leading commercial cell therapy company.

Previous positions held by Dr. Preti include scientific and laboratory director of Hackensack University Medical Center’s stem cell processing and research laboratory in New Jersey and scientific director of the Clinical Services Division at the New York Blood Center, New York City.

He is one of the country’s leading authorities on cell engineering, advanced cell and gene therapy manufacturing, testing and delivery, and regulatory aspects relating to the cell therapy and regenerative medicine industry. He has been the principal investigator for a number of clinical trials relating to the clinical testing of cellular therapies.